Karin Gustafsson, Madeleine Ingelsten, Linda Bergqvist, Jenny Nyström, Bengt Andersson, and Alex Karlsson-Parra

Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine

Cancer Research 2008 68: 5965-5971. doi: 10.1158/0008-5472.CAN-07-6494

J. Alder, K. Gustafsson, A. Wallgren, B. Andersson1, E. Jennische, L. Pellettieri, V. d´Angelo, P. Eriksson, S. Lange, A. Karlsson-Parra

Allogeneic monocyte-derived cells loaded with tumor antigens as a combined antigen-delivery vehicle and adjuvant in cancer immunotherapy

Cancer Immunology and Immunotherapy: Abstract 3

K. Gustafsson, M. Persson, L. Bergqvist, J. Alder, J. Nyström, B. Andersson, L. Pellettieri, V. d´Angelo, P. Eriksson, A. Karlsson-Parra

Profuse and sustained production of MIG/CXCL9 by a clinical grade dendritic cell vaccine: A feature to provide NK cell-dependent boosting for TH1 polarization

Cancer Immunology and Immunotherapy: Abstract 2

L. Bergqvist, S. Holmgren, S. Johnson, K. Gustafsson, J. Alder, B. Andersson, L. Pellettieri, V. d´Angelo, P. Eriksson, A. Karlsson-Parra

The TLR8 agonist R848 primes human monocyte-derived dendritic cells for a secondary, CD40-dependent, burst of IL-12p70 production

Cancer Immunology and Immunotherapy: Abstract 1

A. C. Wallgren, B. Anderssony, A. Bäcker and A. Karlsson-Parra

Direct Allorecognition Promotes Activation of Bystander Dendritic Cells and Licenses Them for Th1 Priming: A Functional Link Between Direct and Indirect Allosensitization

Scandinavian Journal of Immunology 62, 234–242, PDF